Royalty Reporting Sample Clauses

Royalty Reporting. After the first sale anywhere in the Territory, within twenty

Royalty Reporting. After the first sale anywhere in the Territory, within 10 Business Days following the end of each Calendar Quarter, Licensee shall deliver to MPP a statement accounting for, inter alia, all royalties calculations, Licensed Products and/or Compound (in terms of smallest units and patient packs for each formulation) sold or supplied by Licensee under this Agreement during such Calendar Quarter in the reporting template as set forth in Appendix 4. For the avoidance of doubt, such royalty reports shall include sales for which no royalty payment may be due and payable. MPP agrees that information contained in quarterly and other such reports shall be treated as Confidential Information, provided, however, that such information may be shared with Shionogi (with Shionogi treating such reports as Confidential Information).

Royalty Reporting. For each quarter, Licensee shall deliver to UGARF a written report in the form provided at Exhibit B providing all applicable sales, royalty, and other information as set out on Exhibit B (each, a “Royalty Report”). Licensee shall deliver Royalty Reports to UGARF on the same schedule as Royalty Payments, and specifically Licensee shall deliver Royalty Reports to UGARF four (4) times per year, one for each calendar quarter, with each Royalty Report due at the earlier of the date the associated Royalty Payment is delivered or sixty (60) days after the close of the calendar quarter to which it relates.

Royalty Reporting. In conjunction with each payment, Company shall provide UWMRF a written report, the first such report being due and related to the quarter in which the first Net Sales occurred, having sufficient detail to allow a determination of the royalties due UWMRF pursuant to this Agreement. Each report provided to UWMRF shall contain at least the following information using the template found in Exhibit 3: a. the gross dollar and number of unit sales of Licensed Products Sold by Company, its Affiliates in each country; and, b. the calculation of Net Sales for Licensed Products Sold by Company or its Affiliates in each country; and, c. the total royalties payable to UWMRF in U.S. Dollars, together with the exchange rates used for conversion; and, d. a statement that no royalties are due, if no royalties are due to UWMRF for any reporting period after the first Sale of a Licensed Product; and, e. direct fees and revenue, or in the case of non-cash consideration, the cash value of such consideration received by Company from any sublicensee pursuant to any sublicense agreement, for the purposes of calculating amounts due UWMRF pursuant to Article 3.5 hereof.

Royalty Reporting. POINT shall provide to the Licensor written reports within [***] days following the end of Calendar Half Year in the Calendar Year for which royalties are due, setting out (i) the Net Sales of Product in the Territory sold by POINT, its Affiliates and Sublicensees during that Calendar Half Year; (ii) a calculation of the amount of royalties due on Net Sales during such Calendar Half Year; (iii) the exchange rates used, if any, in determining the amount due or performing any necessary currency conversion; and (iv) any withholding Taxes required to be paid from such royalties (combined within each Calendar Year, such Calendar Half Year written reports constitute the “Annual Royalty Report”). The information in the Annual Royalty Report will be deemed POINT’s Confidential Information.

Royalty Reporting. Before the Reporting Deadline for each Reporting Period, Registrant shall submit to Philips (even if no Sales have been made) a Royalty Reporting Form setting forth for all Royalty‐Bearing Products Sold during the Reporting Period: (a) the identity of each customer, and for each customer, particulars of each Royalty‐Bearing Product including: (i) trademark or brand; (ii) model name(s) or code; (iii) country of manufacture; and (iv) name of manufacturer entity; (b) for each Royalty‐Bearing Product identified in Subpart (a), specify (i) each country of Sale, (ii) the total quantity of Sales for such country, and (iii) the total quantity of Sales in the Patent Country for the relevant category of Royalty‐Bearing Product; (c) in the case of Pre‐Paid Periods, the total quantity of Royalty‐Bearing Products for which royalties remain due, calculated as the total number of Royalty‐Bearing Products Sold in the Reporting Period, less any quantities of Royalty‐Bearing Product properly pre‐paid; (d) the royalties due for the Reporting Period, calculated as the total quantity of Royalty‐Bearing Products Sold during the Reporting Period for which royalties remain due multiplied by the Per‐Unit Portfolio Rate or the Essentials Rate as applicable (“Royalties Due”); (e) the Pre‐payment Amount for the any Pre‐paid Period as may be applicable; and (f) the total sum of the Royalties Due and any Pre‐payment Amount for the Pre‐Paid Period (“Balance Due”). If Registrant is qualified and elects to pre‐pay royalties at the Committed Volume Portfolio Rate during the current Reporting Period, Registrant shall specify such pre‐ payment, the relevant Reporting Period, the quantity of Royalty‐Bearing Products to be pre‐paid and the Pre‐payment Amount in the space provided on Page 2 (Pre‐payment Request) of the Royalty Reporting Form. If Registrant, its Affiliates or any of their re‐sellers have Sold Scope Products that are not otherwise Royalty‐Bearing Products in a country that is not a Patent Country, Registrant shall include in the Royalty Reporting Form the information specified in Subparts 2.06(a) and 2.06(b)in respect of such products. For the avoidance of doubt, the initial Reporting Period hereunder shall be the first partial or full calendar quarter after the Effective Date. Registrant shall certify in the Royalty Reporting Form the total amount of royalties due for the preceding Reporting Period, even if no royalties are due, in accordance with the requirements of the Royalty...

Royalty Reporting. Royalties payable by either Party to the other shall be reported on a monthly rather than a quarterly basis. Each Party shall include all reasonably necessary detail to allow the other Party to verify calculations made pursuant to such monthly royalty reports.

Royalty Reporting. Royalties shall be calculated and reported for each calendar year within [***] after the end of each calendar year. With delivery of such report, Licensee shall also pay the corresponding amount of the royalty due to WuXi Biologics, if any. Each report of royalties shall include Annual Net Sales by Licensee and its Affiliates in the Territory on a country-by-country basis for each Licensed Product during the applicable calendar year, which report shall include the gross amounts invoiced and Annual Net Sales, the royalties payable, how such royalties were calculated (including an accounting of any reductions in applicable royalty rates and/or summary of deductions in determining Annual Net Sales), and the exchange rates used, in each case presented on a country-by-country basis for each Licensed Product, and only for the applicable calendar year. Such reports shall be the Confidential Information of Licensee.

Royalty Reporting. Licensee shall furnish written royalty reports to Bitstream within thirty (30) days after the end of each calendar quarter indicating the number of Systems incorporating Typefaces, Outlines and Derivative Works thereof and shipped to Licensee’s customer or OEM during the preceding calendar quarter. A royalty report form is attached hereto as Attachment 1.

Royalty Reporting. Royalties shall be calculated and reported for each calendar quarter within [***] days after the end of each calendar quarter. With delivery of such report, Arcus shall also pay the corresponding amount of the royalty due to WuXi, if any. *** CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. Each report of royalties shall include Net Sales by Arcus and its Affiliates in the Territory on a country-by-country basis for each Licensed Product during the applicable calendar quarter, which report shall include the gross amounts invoiced and Net Sales, the royalties payable, how such royalties payable amounts were calculated (including an accounting of any reductions in applicable royalty rates and/or deductions in determining Net Sales), and the exchange rates used, in each case presented on a country-by-country basis for each Licensed Product, and only for the applicable calendar quarter.